New rounds

Labquality is actively following the development of laboratory medicine and we want to produce clinically relevant EQA schemes to serve clinical laboratories and point-of-care sites. We launch new pilots studies on a regular basis and aim to increase our EQA portfolio with 5-10 new EQA schemes every year.

 


 

Planned pilot studies for 2022


Labquality is planning new EQA pilot studies for 2022. The pilots will be free of charge for a limited number of participants. If you have registered for one or more pilots from the list below, we will send you more information as the pilot approaches.

The following three new pilot studies will be conducted in September/October 2022. Please register by 15th August, 2022 . If you have already registered through the general pilot study registration link, no further actions are needed. This page will be updated as further studies are scheduled.


 

New scheme: Salivary Cortisol

Labquality is announcing a new EQA scheme for Salivary Cortisol. The scheme is suitable for different assays measuring salivary cortisol in clinical samples. Please register by 15th August, 2022.

Read more >>

New scheme: Chemokine CXCL13

Labquality is announcing a new EQA scheme for Chemokine CXCL13, a biomarker for neuroborreliosis. Pilot round includes two samples that should be analysed as regular patient samples. Please register by 15th August, 2022.

Read more >>

New scheme: Interferon Gamma Release Assay (IGRA) for Mycobacterium tuberculosis

Labquality is announcing a new EQA scheme for Interferon Gamma Release Assay (IGRA) for Mycobacterium tuberculosis. The scheme is suitable for different ELISA assays measuring the cell-mediated response to specific tuberculosis antigens in whole blood. The sample sets are sold out and we can only accept registrations for a waiting list. Please register by 15th August, 2022.

Read more >>

Faecal Elastase

Labquality is announcing a new EQA scheme for faecal elastase. In the pilot study, two lyophilized faecal samples of different elastase concentration will be included. The registration for this pilot study is closed. 

Read more >>

Fungal infections, nucleic acid detection

Labquality is announcing a new EQA scheme for direct nucleic acid detection of fungal infections. The scheme samples may contain yeasts, moulds and dermatophytes and it will be suitable for different nucleic acid test panels. The registration for this pilot study is closed. 

Read more >>

Mycobacterium tuberculosis, rifampicin and isoniazid, nucleic acid detection

Labquality is announcing a new EQA scheme for nucleic acid detection of Mycobacterium tuberculosis including samples containing rifampisin and isoniazid resistance. The scheme is suitable for nucleic acid test panels and scoring is based on the qualitative interpretation. The registration for this pilot study is closed. 

Read more >>

New scheme: Adrenocorticothropic hormone ACTH and Cortisol

Labquality is announcing a new pilot study for two hormones ACTH and cortisol. The registration for this pilot study is closed. 

Read more >>

New scheme: HSV1&2 / VZV / T. pallidum, nucleic acid detection

Labquality is announcing a new pilot study for nucleic acid detection of four pathogens included in a four-plex sample. The included pathogens are HSV1&2, VZV and Treponema pallidum. The registration for this pilot study is closed. 

Read more >>

New EQA development: EQA for next-generation sequencing methods

Labquality is developing external quality assessment for NGS methods in microbiology. If you are interested, please contact us!

 All planned pilot studies for 2022

Clinical chemistry: ACTH, Adrenocorticotropic hormone
Clinical chemistry:
Haemoblobin and Haematocrit for POCT
Clinical chemistry:
Cortisol of saliva
Immunology: 
Chemokine CXCL13, biomarker for neuroborreliosis 
Microbiology:
Mycobacterium tuberculosis, rifampicin and isoniazid, nucleic acid detection

 

Microbiology: Quantiferon/IGRA – Interferon gamma releasing assay for tuberculosis diagnostics
Microbiology: Blood culture pathogens (sepsis), multiplex, nucleic acid detection
Virology: West Nile virus, antibody detection
Mycology: Fungal infection, direct nucleic acid detection
Mycology: Fungal infection, native and fluorescence virtual microscopy
Parasitology: Leishmania, nucleic acid detection or antibody detection

New scheme: Preanalytics, Pneumatic Sample Transport

New EQA scheme for Preanalytics of Pneumatic Sample Transport has been released . The round allows measurements of up to three transport lines. The Pilot study for this scheme has been completed in 2021.
The round for this year will be arranged in September. Please check the product catalog for the schedules of 2022 rounds.

Read more >>

New scheme: Interleukin-6

New EQA scheme for Interleukin-6 (IL-6). IL-6 is one of the major cytokines associated with Covid-19 induced cytokine storm. With the Covid-19 pandemic, there has been an increasing request for IL-6 EQA, which Labquality is proud to fulfil with this new EQA scheme. The pilot study for this scheme has been completed in 2021.
Please check the product catalog for the schedules of 2022 rounds.

New scheme: Ketones (beta-hydroxybutyrate)

New EQA scheme for ketones (beta-hydroxybutyrate). Beta-hydroxybutyrate, also know as 3-hydroxybutyrate, is the most abundant of ketones produced during either diabetic ketoacidosis or ketosis. The pilot study for this scheme has been completed in 2021.
The first round for this year will be arranged in July. Please check the product catalog for the schedules of 2022 rounds.

Contact us for more information!

Pin It on Pinterest

Share This